NCT05175482

Brief Summary

To evaluate impact of Health Belief Model Based Education on Human Papilloma Virus Infection and Vaccination among University Students

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
127

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 12, 2021

Completed
18 days until next milestone

Study Start

First participant enrolled

December 30, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 3, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2022

Completed
Last Updated

October 7, 2022

Status Verified

October 1, 2022

Enrollment Period

6 months

First QC Date

December 12, 2021

Last Update Submit

October 6, 2022

Conditions

Human Papilloma VirusHealth Behavior

Outcome Measures

Primary Outcomes (2)

  • Change from baseline assessment of knowledge level on Human Papilloma Virus (HPV) Infection and Vaccination at first day

    The scale consists of 10 items. A higher score represents a higher knowledge level.

    baseline and next day after the education (at first day)

  • Change from baseline score of Human Papilloma Virus (HPV) Infection and Vaccination Health Belief Model Scale at first day

    The scale consists of 14 items. The construction of the scale consists of perceived severity (n=4 items), perceived susceptibility (n=2 items), perceived benefit (n=3 items), perceived barriers (n=5 items). A 4-point Likert scale was used to assess each item.

    baseline and next day after the education (at first day)

Study Arms (2)

Education received group

EXPERIMENTAL

Health belief model based education on HPV infection and vaccination

Other: Virtual Education

Control Group

NO INTERVENTION

No virtual education

Interventions

Virtual EducationOTHER

health belief model based virtual education

Education received group

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • University students aged 18 years or over

You may not qualify if:

  • University students have been received HPV vaccine

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marmara University

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Health Behavior

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Betul Okuyan

    Marmara University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc.Prof.

Study Record Dates

First Submitted

December 12, 2021

First Posted

January 3, 2022

Study Start

December 30, 2021

Primary Completion

June 15, 2022

Study Completion

September 30, 2022

Last Updated

October 7, 2022

Record last verified: 2022-10

Locations

TU(1)